Zydus Wellness Ltd (BOM:531335)
₹ 1891.45 -37.3 (-1.93%) Market Cap: 120.36 Bil Enterprise Value: 120.48 Bil PE Ratio: 39.56 PB Ratio: 2.25 GF Score: 93/100

Q4 2024 Zydus Wellness Ltd Earnings Call Transcript

May 14, 2024 / 10:30AM GMT
Release Date Price: ₹1720.95 (+2.06%)

Key Points

Positve
  • Zydus Wellness Ltd (BOM:531335) registered a consolidated net sales growth of 9.6% year-on-year, with 5.5% attributed to volume growth.
  • The personal care segment, including Everyuth and Nycil, continues to register strong double-digit growth.
  • The company reported a profit after tax of INR1,503 million, with adjusted PAT growing by 24.7% year-on-year.
  • The company's research and development capabilities have led to new product launches, such as Glucon-D Activors and Iamlite.
  • Zydus Wellness Ltd (BOM:531335) has seen an improvement in gross margins by 377 basis points year-on-year for Q4 FY24.
Negative
  • EBITDA for the full year was down by 8.6% year-on-year to INR3,082 million.
  • The company's net debt stood at INR77 million, indicating some level of financial leverage.
  • The food and nutrition segment reported only mid-single-digit value growth for the quarter.
  • There was a significant increase in advertisement expenses by 41.6% year-on-year, which may impact profitability.
  • The company faces competition from local players, particularly in the personal care space, affecting market share.
Operator

Ladies and gentlemen, good day and welcome to Zydus Wellness Q4 FY24 earnings conference call hosted by ICICI Securities Limited. Before we get started, I would like to remind you that the Q&A session is only for institutional investors and analysts and therefore, if there is anybody else who is not an institutional investor or analyst but would like to ask questions, please directly reach out to the Zydus Wellness Investor Relations Team. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Karan Bhuwania from ICICI Securities. Thank you and over to you, Mr. Bhuwania.

Karan Bhuwania
ICICI Securities Limited - Analyst

Thank you, Neerav. Good evening, everyone, and welcome to Q4 FY24 results conference call of Zydus Wellness. From the management today, we have Dr. Sharvil Patel, Chairman; Mr. Tarun Arora, CEO; Mr. Ganesh Nayak, Director; Mr. Umesh Parikh, CFO. I would now like to hand over the call to Mr. Tarun Arora for his opening remarks post which we can open for Q&A session. Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot